Results 41 to 50 of about 917,291 (368)
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency
Riboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised by pontobulbar palsy, sensorineural deafness, sensory ataxia, muscle weakness, optic atrophy and respiratory failure.
Jack R Fennessy+3 more
semanticscholar +1 more source
Update on riboflavin and multiple sclerosis: a systematic review [PDF]
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Riboflavin plays an important role in myelin formation, and its deficiency is implicated as a risk factor for multiple sclerosis.
Mahshid Naghashpour+4 more
doaj +1 more source
Clinical riboflavin deficiency is common in low- and middle-income countries, whilst sub-optimal riboflavin status may be much more prevalent globally than generally recognized, including in high-income countries.
Bethany Duffy+6 more
doaj +1 more source
Riboflavin is an essential micronutrient and a precursor of flavin mononucleotide and flavin adenine dinucleotide for maintaining cell homeostasis. Riboflavin deficiency (RD) induces cell apoptosis.
Bo Zhang+7 more
semanticscholar +1 more source
Vitamin B2, also known as riboflavin, is essential for maintaining human health. The purpose of this study was to isolate novel lactic acid bacteria that overproduce vitamin B2 and to validate their potential as probiotics.
Joo-Yun Kim+6 more
doaj +1 more source
(1) Background: Riboflavin transporter deficiency (RTD), formerly known as Brown–Vialetto–Van Laere syndrome, is a rare condition that causes a progressive neurological syndrome in early life with features of auditory and optic neuropathy, weakness of ...
Lin Zhang, Dominic Thyagarajan
doaj +1 more source
Early detection of congenital disorders by newborn screening (NBS) programs is essential to prevent or limit disease manifestation in affected neonates.
Marne C. Hagemeijer+12 more
doaj +1 more source
A novel ETFDH mutation identified in a patient with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. [PDF]
Ou Y+6 more
europepmc +2 more sources
Riboflavin transporter deficiency: <i>AAV9-SLC52A2</i> gene therapy as a new therapeutic strategy. [PDF]
Mei C+9 more
europepmc +2 more sources
We are reporting monochorionic, diamniotic twin premature infants born at 25 weeks and 6 days gestation with riboflavin (vitamin B2) and biotin (vitamin B7) deficiency, while on prolonged total parenteral nutrition (TPN) during vitamin shortage.
Mohammad Amin Adie MD+7 more
doaj +1 more source